Volume: 6 Issue: 1
Year: 2018, Page: 26-29,
Background: Hepatitis B virus infection is a significant public health problem not only in India but worldwide. Vertical transmission and hepatitis B virus infection early in childhood leads to more chances of progression to chronic liver disease, liver cirrhosis and liver cancer. It will remain so until appropriate and effective nationwide vaccination programmes and other control measures are established.
Objectives: This study was aimed to investigate the seroprevalence of hepatitis B surface antigen (HBsAg) among pregnant women.
Materials and Methods : The present hospital record-based, cross sectional study was conducted at the rural based tertiary care teaching hospital, in Northern Telangana, India, from October 2015 to July 2017. The screening for HBsAg, in all the serum samples collected from pregnant women, was performed using commercial rapid immunoassay kits (HEPACARD - Diagnostic Enterprises, H.P. India). The data of those, who were found to be positive for HBsAg was statistically analyzed with the chi-square test, and results were considered significant if the p value was <0.05.
Results :The overall HBsAg seroprevalence rate was 0.9%, among the total 1411 pregnant women included in this study. HBsAg seroprevalence was highest, 1.4% in 18-20 years of age group, 1.1% in the second trimester of pregnancy and 1.5% in primigravidae. The correlations of seroprevalence rate of HBsAg among selected age groups and according to trimester of pregnancy and parity were not found statistically significant. (p value > 0.05)
Conclusion : In this study, the overall HBsAg seroprevalence rate was 0.9 %. This study recommends that pregnant women should be screened for HBsAg at the first antenatal clinic visit for appropriate management and effective prevention of vertical transmission.
Keywords: Hepatitis B surface antigen (HBsAg), pregnant women, seroprevalence
1. Ananth Narayan, Paniker. Text Book of Microbiology, 9th Ed, Universities Press, India, 2013; pp 540-48.
2. WHO: Hepatitis B. Fact Sheet No.204. World Health Organization. (Reviewed July 2017) (http://www.who.int/ mediacentre/factsheets/fs204/en/)
3. WHO: Hepatitis B. Fact Sheet_B_CTC.cdr 2016 http:// www.searo.who.int/india/topics/hepatitis/ factsheet_b__hepatitisday2016.pdf?ua=1
4. Horvat RT, Tegtmeier GE. Hepatitis B and D viruses. Manual of Clinical Microbiology. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA and Yolken RH.editors. Washington D.C: ASM Press.2003:1464-78.
5. Patton H, Tran TT. Management of Hepatitis B during pregnancy. Nat Rev Gasteroenterol Hepatol 2014;11:402- 49.
6. Dwivedi M, Mishra P et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011;30:66-71.
7. Saraswathi KS, Farhana Aljabri. The study of prevalence of Hepatitis B surface antigen during pregnancy in a tertiary care hospital, South India. Der Pharmacia Lettre 2012;4:983-85.
8. Shazia Parveen S, Shyamala R, Janardhan Rao R, Rama Rao MV. Sero-prevalence of Hepatitis B surface antigen among pregnant women attending antenatal clinic in a teaching hospital. J Microbiol Biotech Res 2012;2:343–45.
9. Chatterjee S, Ravishankar K, Chaterjee R, Narang A, Kinikar A. Hepatitis B prevalence during pregnancy. Indian Pediatr 2009;46:1005-8.
10. Sathiyakala R, Ushadevi G, Karthika J. Seroprevalence of Hepatitis B infection among pregnant women in South India. Int J Reprod Contracept Obstet Gynecol 2017;6:249- 51.
11. Shyamala R. and Janardhan Rao. The study of prevalence of hepatitis B surface antigen in a tertiary care hospital in South India. Der Pharmacia Lettre 2013;5:11-12.
12. Pande C, Sarin SK, Patra S. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol 2011;83:962-67.
13. Sibia P. Seroprevalence of Hepatitis B Infection among Pregnant Women in One of the Institute of Northern India. Journal of Clinical and Diagnostic Research. 2016;10:QC08-9.
14. Ambade VC, Bhushan I, Sinha R. Seroprevalence of Hepatitis B surface antigen among pregnant women in rural based teaching hospital of Northern Maharashtra, India. Int J Med Sci Public Health 2014;3:1439-41.
15. Mehta KD, Antala S, Mistry M, Goswami Y. Seropositivity of hepatitis B, hepatitis C, syphilis, and HIV in antenatal women in India. J Infect Dev Ctries 2013; 7:832-37. doi:10.3855/jidc.2764
16. Khakhkhar VM, Bhuva PJ, Bhuva SP, Patel CP, Meera S C. Sero-prevalence of hepatitis b amongst pregnant women attending the antenatal clinic of a tertiary care hospital, jamnagar (Gujarat). Natl J Med Res 2012;2:362–65.
17. Banerjee A, Chakravarty R,Mondal PN, Chakraborty M.Hepatitis B virus genotype D infection in antenatal patients attending a maternity hospital in Calcutta; South East Asian J. Trop Med Public Health 2005;36:203-20.
18. Sinha A, Sharan M, Shahi SK. Seroprevalence of Hepatitis B Virus in Pregnant Women at a Tertiary Care Hospital of Eastern India. National Journal of Laboratory Medicine. 2016; DOI: 10.7860/NJLM/2016/21657:2151.
19. Paranjothi S, Vijayarani H. Prevalence of hepatitis b virus surface antigen in pregnant women attending a private hospital in krishnagiri. Adv Bio Tech. 2009;9:38–40.
20. Bakthavatchalu S. Hepatitis B surface antigen carrier state among asymptomatic pregnant women and its correlation with vertical transmission. Int J Res Pharm Sci 2012;2:111– 20.
21. Prakash C, Sharma RS, Bhatia R, Verghese T, Datta KK. Prevalence of North India of hepatitis B carrier state amongst pregnant women. Southeast Asian J Trop Med Public Health 1998;29:80-4.
22. Metaferia Y, Dessie W, Ali I, Amsalu A. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based crosssectional study. Epidemiology and Health 2016;38:e2016027. doi:10.4178/epih.e2016027.
23. Afzali H, Momen Heravi M, Moravveji SA, Poorrahnama M. Prevalence of hepatitis B surface antigen in pregnant women in Beheshti hospital of Kashan, Isfahan. Iran Red Crescent Med J 2015;17:e20598.
24. Adegbesan-Omilabu M, Okunade K, Gbadegesin A, Olowoselu O, Oluwole A, Omilabu S. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a Tertiary Hospital in Lagos Nigeria. Niger J Clin Pract 2015;18:819-23.
25. Khattak ST, Ali Marwat M, Khattak Iu, Khan TM, Naheed T. Comparison of frequency of hepatitis B and hepatitis C in pregnant women in urban and rural area of district Swat. J Ayub Med Coll Abbottabad 2009;21:12-5.
26. Alrowaily MA, Abolfotouh MA, Ferwanah MS. Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol 2008;14:70–2.
Palange P, Mohan Rao B. Seroprevalence of Hepatitis B surface antigen among pregnant women attending rural based tertiary care teaching hospital in Northern Telangana, India: A cross sectional study. Perspectives in Medical Research 2018;6(1):26-29.